As of today (2024-04-23), United Therapeutics's current share price is $234.36. United Therapeutics's E10 for the quarter that ended in Dec. 2023 was $12.96. United Therapeutics's Shiller PE Ratio for today is 18.08.
The historical rank and industry rank for United Therapeutics's Shiller PE Ratio or its related term are showing as below:
UTHR'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.81 Med: 21.68 Max: 80.06
Current: 18.09
During the past years, United Therapeutics's highest Shiller PE Ratio was 80.06. The lowest was 10.81. And the median was 21.68.
UTHR's Shiller PE Ratio is ranked better than 73.43% of 143
companies
in the Biotechnology industry
Industry Median: 32.57
vs UTHR: 18.09
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
United Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was $4.360. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $12.96 for the trailing ten years ended in Dec. 2023.
Shiller PE for Stocks: The True Measure of Stock Valuation
United Therapeutics Shiller PE Ratio Historical Data
The historical data trend for United Therapeutics's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, United Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
United Therapeutics Shiller PE Ratio Distribution
For the Biotechnology industry and Healthcare sector, United Therapeutics's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where United Therapeutics's Shiller PE Ratio falls into.
United Therapeutics Shiller PE Ratio Calculation
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
United Therapeutics's Shiller PE Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Therapeutics's E10 for the quarter that ended in Dec. 2023 is calculated as:
For example, United Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was:
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
United Therapeutics (NAS:UTHR) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
United Therapeutics Shiller PE Ratio Related Terms
Thank you for viewing the detailed overview of United Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
United Therapeutics (United Therapeutics) Business Description
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
UTHR has been successfully added to your 